Drug · DIN 02553619
BIMZELX
PREFILLED SYRINGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 7, 2025; first marketed April 7, 2025.
- Drug Identification Number (DIN)
- 02553619
- Company (DIN owner)
- Ucb Canada IncOakville, Ontario, Canada
- Schedule
- Prescription; Schedule D
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Bimekizumab L04AC21
- Class
- Human
- Record last updated
- January 15, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BIMEKIZUMAB | 320 MG | 2 ML |
Other DINs named BIMZELX
- DIN 02525267 · Marketed
- DIN 02525275 · Marketed
- DIN 02553627 · Marketed